Hypoxia downregulates the expression of activating receptors involved in NK‐cell‐mediated target cell killing without affecting ADCC. Issue 10 (5th August 2013)
- Record Type:
- Journal Article
- Title:
- Hypoxia downregulates the expression of activating receptors involved in NK‐cell‐mediated target cell killing without affecting ADCC. Issue 10 (5th August 2013)
- Main Title:
- Hypoxia downregulates the expression of activating receptors involved in NK‐cell‐mediated target cell killing without affecting ADCC
- Authors:
- Balsamo, Mirna
Manzini, Claudia
Pietra, Gabriella
Raggi, Federica
Blengio, Fabiola
Mingari, Maria Cristina
Varesio, Luigi
Moretta, Lorenzo
Bosco, Maria Carla
Vitale, Massimo - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>In certain infection sites or tumor tissues, the disruption of homeostasis can give rise to a hypoxic microenvironment, which, in turn, can alter the function of different immune cell types and favor the progression of the disease. Natural killer (NK) cells are directly involved in the elimination of virus‐infected or transformed cells, however it is unknown whether their function is affected by hypoxia or not. In this study, we show that NK cells adapt to a hypoxic environment by upregulating the hypoxia‐inducible factor 1α. However, NK cells lose their ability to upregulate the surface expression of the major activating NK‐cell receptors (NKp46, NKp30, NKp44, and NKG2D) in response to IL‐2 (or other activating cytokines, including IL‐15, IL‐12, and IL‐21). These altered phenotypic features correlate with reduced responses to triggering signals resulting in impaired capability of killing infected or tumor target cells. Remarkably, hypoxia does not significantly alter the surface density and the triggering function of the Fc‐γ receptor CD16, thus allowing NK cells to maintain their capability of killing target cells via antibody‐dependent cellular cytotoxicity. This finding offers an important clue for exploitation of NK cell in antibody‐based immunotherapy of cancer.</p> </abstract>
- Is Part Of:
- European journal of immunology. Volume 43:Issue 10(2013:Oct.)
- Journal:
- European journal of immunology
- Issue:
- Volume 43:Issue 10(2013:Oct.)
- Issue Display:
- Volume 43, Issue 10 (2013)
- Year:
- 2013
- Volume:
- 43
- Issue:
- 10
- Issue Sort Value:
- 2013-0043-0010-0000
- Page Start:
- 2756
- Page End:
- 2764
- Publication Date:
- 2013-08-05
- Subjects:
- Immunology -- Periodicals
616.079 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/eji.201343448 ↗
- Languages:
- English
- ISSNs:
- 0014-2980
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.730100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3071.xml